South African Biotechnology Startup Immobazyme Secures USD 1.3 M Funding
- Immobazyme, a South African biotechnology start-up, has raised USD 1.3 million in funding.
- The funding round was led by The University Technology Fund and University of Stellenbosch Enterprises.
- Immobazyme utilizes precision fermentation technology to produce high-value active protein ingredients.
The funding secured by Immobazyme is a positive development for the South African biotechnology industry. It will enable the company to expand its production capabilities and contribute to the growth of the sector. Immobazyme's utilization of precision fermentation technology showcases its innovative approach and potential for success.
